As the Canadian market navigates a period of cautious optimism, with the TSX only slightly off its record high thanks to strong performance in sectors like materials, investors are keenly observing how trade developments and pro-growth agendas will shape future trends. In this environment, identifying growth companies with high insider ownership can be particularly appealing, as such stocks often signal confidence from those closest to the business and may offer resilience amid market fluctuations.
Top 10 Growth Companies With High Insider Ownership In Canada
Overview: Allied Gold Corporation, along with its subsidiaries, is involved in the exploration and production of mineral deposits in Africa and has a market cap of CA$1.86 billion.
Operations: The company's revenue segments include $188.89 million from the Agbaou Mine, $206.91 million from the Bonikro Mine, and $334.58 million from the Sadiola Mine.
Insider Ownership: 17%
Allied Gold is positioned for growth with forecasted revenue increases of 25.8% per year, outpacing the Canadian market. Insider ownership remains significant, with more shares bought than sold recently. Despite past shareholder dilution and a net loss of US$115.63 million in 2024, Allied's strategic partnership with Ambrosia Investment Holding aims to enhance financial strength and operational capacity. Recent equity offerings raised CAD 80.25 million, supporting expansion efforts at the Sadiola mine in Mali.
Overview: Knight Therapeutics Inc. is involved in acquiring, in-licensing, out-licensing, marketing, and commercializing prescription pharmaceutical products across Canada and Latin America with a market cap of CA$587.29 million.
Operations: The company's revenue is primarily derived from its pharmaceuticals segment, which generated CA$371.30 million.
Insider Ownership: 22.9%
Knight Therapeutics shows potential for growth with earnings forecasted to grow significantly at 38.2% annually, outpacing the Canadian market. Recent profitability and a substantial revenue increase to CAD 371.3 million in 2024 highlight operational improvements. The launch of Minjuvi® in Mexico and new agreements with Helsinn indicate strategic expansion in Latin America. Although trading below fair value estimates, low forecasted return on equity may be a concern for long-term investors seeking high-quality earnings growth.
Overview: WELL Health Technologies Corp. is a digital healthcare company focused on supporting practitioners in Canada, the United States, and internationally, with a market cap of CA$1.01 billion.
Operations: The company's revenue segments include Saas and Technology Services (CA$72.87 million), Specialized-provider Staffing (CA$123.13 million), Canadian Patient Services - Primary (CA$191.89 million), WELL Health USA Patient Services - Primary WISP (CA$100.97 million), Canadian Patient Services - Specialized Myhealth (CA$127.56 million), WELL Health USA Patient Services - Primary Circle Medical (CA$76.30 million), and WELL Health USA Patient Services - Specialized CRH Medical (CA$234.72 million).
Insider Ownership: 22.6%
WELL Health Technologies demonstrates strong growth prospects with earnings expected to grow significantly at 22.5% annually, surpassing the Canadian market. The company's revenue is forecasted to reach between C$1.40 billion and C$1.45 billion in 2025, reflecting robust expansion beyond last year's C$919.69 million sales figure. Despite a recent net loss in Q4 2024, WELL's full-year net income improved substantially to C$32.61 million, indicating resilient financial performance amidst high-quality earnings potential.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.The analysis only considers stock directly held by insiders. It does not include indirectly owned stock through other vehicles such as corporate and/or trust entities. All forecast revenue and earnings growth rates quoted are in terms of annualised (per annum) growth rates over 1-3 years.
Companies discussed in this article include TSX:AAUC TSX:GUD and TSX:WELL.
